First CAR-T therapy to target BCMA gets FDA nod

被引：14
|
作者：
机构：
来源：
Nature Biotechnology | 2021年 / 39卷 / 5期
关键词：
D O I：
10.1038/s41587-021-00929-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：531 / 531
相关论文
共 50 条
  • [21] Impact of corticosteroids on efficacy of BCMA targeted CAR-T therapy in multiple myeloma
    Duvalyan, Eva
    Shah, Nina
    Lo, Mimi
    Martin III, Thomas
    Wolf, Jeffrey L.
    Chung, Alfred
    Arora, Shagun
    Huang, Chiung-Yu
    Wong, Sandy W.
    LEUKEMIA & LYMPHOMA, 2023,
  • [22] Reconstitution of the Multiple Myeloma Microenvironment Following Lymphodepletion with BCMA CAR-T Therapy
    Yang, Yazi
    Qin, Sen
    Yang, Mengyu
    Wang, Ting
    Feng, Ru
    Zhang, Chunli
    Zheng, Enrun
    Li, Qinghua
    Xiang, Pengyu
    Ning, Shangyong
    Xu, Xiaodong
    Zuo, Xin
    Zhang, Shuai
    Yun, Xiaoya
    Zhou, Xuehong
    Wang, Yue
    He, Lin
    Shang, Yongfeng
    Sun, Luyang
    Liu, Hui
    CLINICAL CANCER RESEARCH, 2024, 30 (18) : 4201 - 4214
  • [23] Impact of Corticosteroids on Efficacy of BCMA Targeted CAR-T Therapy in Multiple Myeloma
    Duvalyan, Eva
    Lo, Mimi
    Martin, Thomas
    Wolf, Jeffrey L.
    Chung, Alfred
    Arora, Shagun
    Shah, Nina
    Huang, Chiung-Yu
    Wong, Sandy W.
    BLOOD, 2021, 138
  • [24] Bluebird's BCMA CAR-T impresses at ASH
    不详
    NATURE BIOTECHNOLOGY, 2018, 36 (01) : 11 - 11
  • [25] Phosphatidylserine as a tumor target for CAR-T cell therapy
    Martin-Otal, Celia
    Sanchez-Moreno, Ines
    Gomez-Moron, Alvaro
    Castro, Carla
    Casares, Noelia
    Navarro, Flor
    Gorraiz, Marta
    Justicia-Lirio, Pedro
    Pareja, Felix
    Collantes, Maria
    Penuelas, Ivan
    Inarrairaegui, Mercedes
    Sangro, Bruno
    Vivas, Isabel
    Larrayoz, Marta
    Rodriguez, Juan Roberto
    Prosper, Felipe
    Hervas-Stubbs, Sandra
    Martin-Cofreces, Noa
    Lasarte, Juan Jose
    Lozano, Teresa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
  • [26] NOVEL TARGET ANTIGENS FOR CAR-T CELL THERAPY
    Perriello, V. M.
    Falini, B.
    HAEMATOLOGICA, 2022, 107 : 11 - 12
  • [27] Teclistamab impairs detection of BCMA CAR-T cells
    Glatte, Bettina
    Wenk, Kerstin
    Grahnert, Anja
    Friedrich, Maik
    Merz, Maximilian
    Vucinic, Vladan
    Fischer, Luise
    Reiche, Kristin
    Alb, Miriam
    Hudecek, Michael
    Franz, Paul
    Fricke, Stephan
    Platzbecker, Uwe
    Koehl, Ulrike
    Sack, Ulrich
    Boldt, Andreas
    Hauschildt, Sunna
    Weiss, Ronald
    BLOOD ADVANCES, 2023, 7 (15) : 3842 - 3845
  • [28] Bluebird's BCMA CAR-T impresses at ASH
    Nature Biotechnology, 2018, 36 : 11 - 11
  • [29] Post CAR-T lymphocytosis as a surrogate of BCMA CAR-T expansion, response, and prognosis in multiple myeloma
    Saldarriaga, Mateo Mejia
    Pan, Darren
    Unkenholz, Caitlin
    Mouhieddine, Tarek
    Fein, Josh
    Monge, Jorge
    Rosenbaum, Cara
    Pearse, Roger
    Jayabalan, David
    Gordillo, Christian
    Chan, Hei Ton
    Mapara, Markus
    Inghirami, Giorgio
    Lentzsch, Suzanne
    Reshef, Ren
    Rossi, Adriana
    Parekh, Samir
    Jagannath, Sundar
    Richards, Shambavi
    Niesvizky, Ruben
    Bustoros, Mark
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple Myeloma
    Golubovskaya, Vita
    Zhou, Hua
    Li, Feng
    Berahovich, Robert
    Sun, Jinying
    Valentine, Michael
    Xu, Shirley
    Harto, Hizkia
    Sienkiewicz, John
    Huang, Yanwei
    Wu, Lijun
    BIOMEDICINES, 2021, 9 (10)
12345